<DOC>
	<DOCNO>NCT00090519</DOCNO>
	<brief_summary>The purpose study determine ruboxistaurin help slow worsen eye disease call macular edema patient diabetes .</brief_summary>
	<brief_title>Reduction Occurrence Center-Involved Diabetic Macular Edema</brief_title>
	<detailed_description />
	<mesh_term>Macular Edema</mesh_term>
	<mesh_term>Diabetic Retinopathy</mesh_term>
	<mesh_term>Ruboxistaurin</mesh_term>
	<criteria>Type 1 Type 2 diabetes 18 year old Nonclinically significant diabetic macular edema Mild moderate diabetic retinopathy study eye , vitreous hemorrhage study eye Relatively good vision ( 20/30 well ) Surgery laser treatment study eye Glaucoma study eye Glycosylated hemoglobin ( HbA1c ) great 11 % , systolic blood pressure great 170 millimeter mercury ( mmHg ) Liver disease , dialysis renal transplant</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2016</verification_date>
</DOC>